Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2000
11/29/2000EP1054865A1 Farnesyl transferase inhibitors
11/29/2000EP1054861A1 Cytostatic agents
11/29/2000EP1054859A1 Processes and intermediates useful to make antifolates
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054690A2 Hapten-modified tumor cell membranes and their use
11/29/2000EP1054688A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP1054686A1 Pharmaceutical formulation of a didemnin compound
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP1054680A1 Composition and method for the treatment of bladder cancer
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275076A Method of administering liposomal encapsulated taxane
11/29/2000CN1274751A Artificial culture of Jiuzhou caterpillar fungus and the application of its sporophore
11/29/2000CN1274606A Oral liquid capable of increasing hemogram, strengthening immunity and suppressing tumor during radiotherapy and chemtherapy of cancer
11/29/2000CN1274587A Cancer treating Chinese medicine
11/29/2000CN1058993C Prepn. and use of molecular chimera for treatment of cancer
11/29/2000CN1058892C Drug for curing lung cancer
11/29/2000CN1058882C Oral liquor for treating tumour and preparation method thereof
11/29/2000CN1058878C Medicine for treatment of multiple middle-advanced stage cancer
11/29/2000CN1058871C Tianjianwan and its producing process
11/28/2000US6153736 Modified ether glyceroglycolipids
11/28/2000US6153731 Dehydrodidemnin B
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153651 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/28/2000US6153646 Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes
11/28/2000US6153644 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
11/28/2000US6153642 Useful as antineoplastic and antiviral agents
11/28/2000US6153639 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153622 Estrogen agonists/antagonists
11/28/2000US6153610 For treating cancer tumors
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153600 Administering, in vivo, at or around the site of the solid tumor, a nucleic acid which encodes an ip-10 polypeptide, for inhibiting a solid tumor in a mammal
11/28/2000US6153590 Biologically active peptides and compositions, their use
11/28/2000US6153587 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153391 Contacting p53 and oncoprotein with a peptide fragment or analogue including a defined amino acid sequence or an organic molecule having three-dimensional structure of that amino acid sequence; interferes with binding
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153193 Compositions for targeting biological agents
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/23/2000WO2000070351A2 Protein-protein interactions and methods for identifying them
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070092A1 Expression of ets-domain proteins in cancer
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069862A2 Hemisynthetic method and intermediates thereof
11/23/2000WO2000069860A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000WO2000069859A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000WO2000069856A1 Compounds and therapeutic methods
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069846A1 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
11/23/2000WO2000069839A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069833A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069827A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069822A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069520A2 Use of topical azathioprine to treat inflammatory bowel disorders
11/23/2000WO2000069515A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000069467A1 Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
11/23/2000WO2000069465A1 Anticancer agents containing ep1 antagonists as the active ingredient
11/23/2000WO2000069463A1 Compositions and methods for treating cell proliferation disorders
11/23/2000WO2000069460A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
11/23/2000WO2000069459A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
11/23/2000WO2000069456A2 Adjuvant combination formulations
11/23/2000WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000WO2000069441A1 Compositions and uses of et743 for treating cancer
11/23/2000WO2000069434A1 Dfmo and celecoxib in combination for cancer chemoprevention and therapy
11/23/2000WO2000069413A1 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
11/23/2000WO2000069390A2 Compositions for improving bioavailability of orally administered drugs
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
1 ... 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 ... 2211